Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from TD Cowen

Microsoft Issued a Major Red Flag: Sell These 3 Data Center Stocks Now

Investors may want to ditch these names.

Barchart

Stanley Druckenmiller Bets Big on Airline Stocks – Should You?

Stanley Druckenmiller decided to sell some of the big tech names in his portfolio to replace them with airline stocks today. What was his motive?

MarketBeat

President Trump Wants to Get Rid of Pennies. These 2 ‘Strong Buy’ Stocks Could Be Unlikely Winners.

Visa and Mastercard are emerging as potential beneficiaries, with their digital payment solutions and strong growth prospects making them attractive investments in a cashless future.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Analysts: Buy These 3 Defense Stocks as Trump Pushes for an Iron Dome

New legislation promises to supercharge defense stocks.

Barchart

Why Salesforce Stock Could Be at Fresh Highs by February

One of the reasons we're so excited about Salesforce is the analysts' coverage of the stock. Just last week, TD Cowen upgraded it to a Buy.

MarketBeat

SAP’s Strong Momentum: A Bullish Setup for Investors

With just three weeks gone of the new year, 2025 is already shaping up to be another banner year for SAP. Let's jump in and take a look.

MarketBeat

3 Defensive Stocks Analysts Are Bullish on to Kick Off the Year

Check out these three defensive stocks that Wall Street analysts are upgrading their ratings on in the first few weeks of 2025.

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Decoding 10 Analyst Evaluations For Paycom Software

Across the recent three months, 10 analysts have shared their insights on Paycom Software (NYSE:PAYC), expressing a variety of opinions spanning from bullish to bearish.

Benzinga

The Latest Analyst Ratings For Fiserv

Ratings for Fiserv (NYSE:FI) were provided by 24 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.

Benzinga

20 Analysts Have This To Say About Blackstone

Across the recent three months, 20 analysts have shared their insights on Blackstone (NYSE:BX), expressing a variety of opinions spanning from bullish to bearish.

Benzinga

Cracking The Code: Understanding Analyst Reviews For Amer Sports

Throughout the last three months, 13 analysts have evaluated Amer Sports (NYSE:AS), offering a diverse set of opinions from bullish to bearish.

Benzinga

Deep Dive Into Nike Stock: Analyst Perspectives (34 Ratings)

During the last three months, 34 analysts shared their evaluations of Nike (NYSE:NKE), revealing diverse outlooks from bullish to bearish.

Benzinga

Parker Hannifin Stock: A Deep Dive Into Analyst Perspectives (14 Ratings)

In the latest quarter, 14 analysts provided ratings for Parker Hannifin (NYSE:PH), showcasing a mix of bullish and bearish perspectives.

Benzinga

Expert Outlook: TJX Companies Through The Eyes Of 8 Analysts

In the last three months, 8 analysts have published ratings on TJX Companies (NYSE:TJX), offering a diverse range of perspectives from bullish to bearish.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Expert Ratings For Walgreens Boots Alliance

In the latest quarter, 9 analysts provided ratings for Walgreens Boots Alliance (NASDAQ:WBA), showcasing a mix of bullish and bearish perspectives.

Benzinga

Where Accenture Stands With Analysts

17 analysts have shared their evaluations of Accenture (NYSE:ACN) during the recent three months, expressing a mix of bullish and bearish perspectives.

Benzinga

Key Takeaways From CVS Health Analyst Ratings

CVS Health (NYSE:CVS) has been analyzed by 18 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.

Benzinga

Spotlight on Hims & Hers Health: Analyzing the Surge in Options Activity

Deep-pocketed investors have adopted a bullish approach towards Hims Hers Health (NYSE:HIMS), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in HIMS usually suggests something big…

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Assessing Prudential Financial: Insights From 9 Financial Analysts

Providing a diverse range of perspectives from bullish to bearish, 9 analysts have published ratings on Prudential Financial (NYSE:PRU) in the last three months.

Barchart

1 Standout Stock to Buy at a Discount After Strong Earnings

With Q3 earnings propelling this warehouse retailer to new peaks, investors should seize this opportunity to capitalize on substantial upside potential.

Benzinga

Exxon Mobil Unusual Options Activity For November 26

Deep-pocketed investors have adopted a bearish approach towards Exxon Mobil (NYSE:XOM), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in XOM usually suggests something big is…

Barchart

What Are Wall Street Analysts' Target Price for Revvity Stock?

Revvity has underperformed the broader market this year, but Wall Street analysts remain somewhat optimistic about the stock's future prospects.

Barchart

Stocks Settle Higher as Bond Yields Fall on Trump’s Treasury Secretary Pick

The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.30%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.99%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.14%. Stocks settled higher on Monday, with the S&P 500 and Dow Jones Industrials posting...

Benzinga

Analyst Ratings For Nasdaq

21 analysts have shared their evaluations of Nasdaq (NASDAQ:NDAQ) during the recent three months, expressing a mix of bullish and bearish perspectives.

Benzinga

Decoding 12 Analyst Evaluations For Universal Health Servs

12 analysts have expressed a variety of opinions on Universal Health Servs (NYSE:UHS) over the past quarter, offering a diverse set of opinions from bullish to bearish.

1 2 3 4

People

Stanley Druckenmiller

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.